Officer exercised or converted 670 LH derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Feb 6, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Feb 10, 2026
OfficerOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000920148-26-000033
Filed / recordedFeb 10, 2026, 8:18 PM UTCAdded to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly IssuerLABCORP HOLDINGS INC. Reporting personBrian J Caveney Officer titleEVP, Pres of ED, CMO & CSO SecurityRestricted Stock Unit TableDerivative (Table II) Transaction dateFeb 6, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
- The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.
- This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Around the same time
Traded Feb 11 · disclosed 27 days laterDependent child
2 different filers disclosed LH within 90 days.
Traded Feb 4 · disclosed 34 days laterDependent child
2 different filers disclosed LH within 90 days.
Traded Mar 3 · filed 2 days laterNot under a reported trading plan
The CEO of Labcorp sold $2.44M of Labcorp shares. The filing does not indicate a pre-arranged trading plan.